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Predictors of poor-quality spirometry in two cohorts of older
adults in Russia and Belgium: a cross-sectional study
Eralda Turkeshi1,4, Dmitry Zelenukha2,4, Bert Vaes1,3, Elena Andreeva1, Elena Frolova2 and Jean-Marie Degryse1,3
BACKGROUND: Spirometry is an important test for the diagnosis of respiratory diseases, yet it is underused especially in older
adults. Several predictors of good-quality spirometry in this age group have been reported, based mainly on in/outpatients of
geriatric and/or respiratory units.
AIMS: This study aims to assess predictors of poor-quality spirometry in community-dwelling older adults from two primary care
cohorts in Russia and Belgium.
METHODS: Spirograms from two population-based cohort studies in Russia (CRYSTAL) and Belgium (BELFRAIL) were assessed in
accordance with the American Thoracic Society/European Respiratory Society (ATS/ERS) acceptability and repeatability criteria and
grouped into good and poor quality. Multivariable analysis assessed the association of poor-quality spirometry with socio-
demographics, functional dependency, physical and mental functioning and co-morbidities.
RESULTS: In all, 43.3% of the 522 BELFRAIL participants (84.71 ± 3.67 years old) and 57.7% of the 605 CRYSTAL participants
(75.11 ± 5.97 years old) achieved all ATS/ERS acceptability and repeatability criteria. In both cohorts, those with poor-quality
spirometry had lower cognitive function (mini-mental state examination (MMSE) ⩽ 24). After adjustment in multivariable analysis,
MMSE ⩽ 24 had an odds ratio for poor-quality spirometry of 1.33 (95% CI = 0.78–2.28) in the BELFRAIL and 1.30 (95% CI = 0.88–1.91)
in the CRYSTAL cohort.
CONCLUSIONS: In community-dwelling older adults, including those over 80 years old, impaired cognition measured by the MMSE
may not be an independent predictor of poor-quality spirometry. Further research is needed in this area, and spirometry should be
used more often in older adults in primary care.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is becoming a
major cause of morbidity and mortality, especially in light of the
worldwide trend of population ageing.1 Spirometry is essential for
the diagnosis, assessment of severity and follow-up of COPD and
asthma.2,3 Besides this, spirometry parameters such as forced
expiratory volume in 1 s (FEV1) have been found to be predictors
of adverse health outcomes such as all-cause mortality, disability
and frailty in the older adults.4–8 Yet, there is still underuse of
spirometry for diagnosing respiratory problems, especially in older
adults, even though it has become widely available in primary care
and hand-held office spirometry is reliable.9–12
The quality of spirometry is very important for its interpretation,
and standardisation guidelines are available on acceptability and
repeatability criteria.13 These criteria require at least three
acceptable forced vital capacity manoeuvres, but in older adults
five to eight are needed to meet the quality criteria, and
depending on the setting, the majority of older adults meet
them.14 Several factors that predict good quality of spirometry in
older adults have been identified, such as a skilled operator,
female sex, younger age (65–80), better education, cognitive
function, stamina and mood, as well as the absence of obesity/
malnutrition.14
As previous studies on the quality of spirometry in older adults
have mainly included older adults either as in/outpatients of
geriatric and/or respiratory units,15–20 the aim of this paper is to
assess which of the previously reported factors predict poor-
quality spirometry in community-dwelling older adults from two
different primary care cohorts in Russia and Belgium.
MATERIALS AND METHODS
Study designs and populations
The BELFRAIL study is a prospective, observational, population-based
cohort study of people ⩾ 80 years old living in Belgium aiming to improve
the understanding of the epidemiology and pathophysiology of chronic
diseases in this age group.21 The CRYSTAL study is a prospective cohort
study of community-dwelling individuals aged 65 years and older living in
the Kolpino district of St Petersburg, Russia aiming to provide a picture of
the health and functional status of community-dwelling older adults in this
area.22 The studies’ protocols and sampling methods have already been
described in detail elsewhere.21,22 Briefly, between November 2008 and
September 2009, in 29 general practitioner centres in Belgium, 567
community-dwelling individuals ⩾ 80 years old were recruited in the
BELFRAIL cohort, excluding only those with dementia (known previous
mini-mental state examination (MMSE) score o15) or those in palliative or
emergency care. In the primary care clinic of Kolping in St Petersburg,
Russia between March and December 2009, 611 community-dwelling
adults 465 years old were recruited in the CRYSTAL study. In both the
studies, at baseline, the participants’ general practitioners recorded socio-
demographic data and medical history. An extensive standardised
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assessment by trained clinical research assistants included standardised
biometric measurements, performance tests, questionnaires and technical
tests including spirometry. The studies’ protocols were approved by the
appropriate local ethics committees, and informed consent was obtained
from all the participants.21,22
Spirometry
In both studies, spirometry was performed by trained clinical research
assistants (two at BELFRAIL and four at CRYSTAL study) either at the home
of the participants (BELFRAIL) or at the polyclinic (CRYSTAL), using a
Spirobank spirometer (MIR, Rome, Italy) that has been found to be reliable
for research purposes.23 The spirometer was linked to a computer with the
Winspiro Pro software that provided real-time feedback (in the clinical
research assistant’s language) on the flow-volume curves, as well as an
automated quality analysis. Spirometry was performed according to the
American Thoracic Society/European Respiratory Society (ATS/ERS)
standards.13 Repeatability of the spirometry was automatically calculated
by the software in accordance with the ATS/ERS criteria.13 In both studies,
two independent researchers evaluated all the spirograms by the ATS/ERS
criteria by reviewing the characteristics of the flow-volume curves, as well
as numerical data, and classified them in the following levels: 1—all ATS/
ERS criteria are fulfilled including repeatability; 2—all ATS/ERS criteria are
fulfilled except duration of expiration46 s; 3—spirograms have good starts
and no cough during the first second of manoeuvre; 4—none of the ATS/
ERS criteria are fulfilled. All the participants in both the studies were
grouped into those with good- (ATS 1) or poor (ATS 2–4)-quality spirometry.
Physical and mental functioning
Activities of daily living for BELFRAIL and Barthel Index of daily activities for
CRYSTAL study, as well as physical performance tests (PPT) and grip
strength, were used as measures of physical function.21,22
The total activities of daily living scores in the BELFRAIL study were
ranked in gender-specific quintiles, and the lowest quintile was used as a
proxy for activities of daily living disability. The cutoff for physical
dependency in the CRYSTAL study was Barthel Index score o95.
The physical performance tests in both the studies consisted of
measured times of walking 3 m and return, sitting and standing from a
chair, putting on and taking off a cardigan and maintaining balance in a
tandem stand.21,22 The summary physical performance tests score was
ranked into quartiles with the lowest gender-specific quartile as cutoff for
poor physical performance.
The cutoff for poor grip strength in the BELFRAIL study was the lowest
gender-specific quartile of the best score of three attempts with the
dominant hand.21 In the CRYSTAL study, the gender-specific lowest
quartile of the average score of three attempts with the dominant hand
was used as the cutoff for poor grip strength.22
The MMSE and the 15-item Geriatric Depression Scale (GDS-15) were
used as measures of mental functioning.21,22 Participants were classified
into those with normal cognitive status (25–30 points) and those with
various stages of cognitive impairment (mild: 24–21; moderate: 20–10;
severe: ⩽ 9). The GDS-15 score of ⩾ 5 was used to identify participants at
risk for depression.
Other variables
In addition to age, sex and BMI (body mass index), other variables included
in the statistical analysis were as follows: smoking status (never, previous or
current smoker), co-morbidities (simple disease count for a list of
co-morbidities), dyspnoea (modified Medical Research Council scale) and
level of education (primary, secondary or higher; available only in the
BELFRAIL study).21,22
Statistical analysis
Descriptive statistics were calculated for all variables, with the continuous
variables presented as mean± s.d. or median and interquartile range, and
categorical ones as numbers and frequencies. Comparison of baseline
variables across the two groups of good and poor spirometry quality was
tested with t-test for independent samples for parametric variables, Mann–
Whitney U-test for non-parametric variables and Pearson’s χ2 test for
categorical variables. Multivariable logistic regression was used to estimate
the association of cognitive impairment with poor spirometry quality
(adjusted in three consecutive steps). Variables were first checked for
multicollinearity. Statistical significance was considered at a two-tailed
probability value o0.05. Statistical analysis was performed using SPSS 22.0
for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
The BELFRAIL cohort consisted of 567 participants aged ⩾ 80
years, and 522 performed spirometry during the baseline
assessment. Forty-five participants either refused to have spiro-
metry or it was not possible because of technical reasons. They
had no statistically significant differences from the rest of the
participants regarding baseline characteristics. The quality of
spirograms was scored as ATS 1 in 226 participants (43.3%), ATS 2
in 214 participants (41%), ATS 3 in 61 participants (11.7%) and ATS
4 in 21 participants (4%).
The main baseline characteristics of the BELFRAIL study
population in total and by spirometry quality are shown in
Table 1. Those who achieved all the ATS/ERS spirometry criteria
(good quality) were younger, more often men, previous/current
smokers, with asthma/COPD, higher scores of MMSE, activities of
daily living, grip strength and lower scores of GDS-15.
In multivariable analysis, only female sex, lower education level,
GDS-15 score ⩾ 5 and lack of COPD/asthma were predictors of
poor-quality spirograms (Table 2). The adjusted odds ratio of
impaired cognitive impairment (MMSE ⩽ 24) for poor-quality
spirometry was 1.33 (95% CI = 0.78–2.28).
The CRYSTAL cohort consisted of 611 participants aged ⩾ 65
years, and 605 performed spirometry during the baseline
assessment. The quality of spirometry was ATS 1 in 349
participants (57.7%), ATS 2 in 103 participants (17%), ATS 3 in 32
participants (5.3%) and ATS 4 in 121 participants (20%).
The main baseline characteristics of the CRYSTAL study
population in total and by spirometry quality groups are shown
in Table 3. There were statistically significant differences between
those with good and poor spirometry quality only regarding
MMSE score. MMSE score ⩽ 24 had an adjusted odds ratio of 1.30
(95% CI = 0.88–1.91) for poor-quality spirometry (Table 4).
DISCUSSION
Main findings
In two cohorts of community-dwelling older adults in Belgium and
Russia, even though there were more participants with MMSE ⩽ 24
in the group with poor-quality spirometry, in multivariable analysis
impaired cognition (MMSE ⩽ 24) was not found to be an
independent predictor of poor-quality spirometry. In the BELFRAIL
cohort, female sex, lower level of education, GDS-15 score ⩾ 5 and
lack of COPD/asthma diagnosis were found to be independent
predictors of poor-quality spirometry.
Interpretation of findings in relation to previously published work
Previous studies on factors affecting the ability of older adults
(mean age of 71 to 85 years) to perform good-quality spirometry
have reported success rates ranging from 20% in acute care
geriatric units’ patients up to 94% in community-dwelling
participants, using different definitions of good-quality spirometry
(either fulfilment of acceptability criteria only or both acceptability
and repeatability criteria by ATS94 or ATS/ERS).15–18,20,24–27 In our
two cohorts of community-dwelling older adults, 84.3% of the
BELFRAIL participants and 74.7% of the CRYSTAL ones performed
spirometry that fulfilled all the ATS/ERS criteria except for the
duration of expiration46 s (levels ATS 1 and 2). Lack of a plateau
of more than 6 s should not classify spirograms as not usable for
analysis and interpretation of lung function.13,28 FEV1/FEV6 has
been found to be an appropriate substitute of FEV1/forced vital
capacity, and spirometers that measure FEV6 and provide lower
limit of normal ranges are available.14,29–33 The role of FEV1/FEV3
has been explored as well.18,34 In addition, FEV1 as a potential risk
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Table 2. Multivariable logistic regression analysis of the association between MMSE score and poor spirometry quality in the BELFRAIL study
Variables Unadjusted Model 1 Model 2 Model 3
MMSE (⩽24) 1.84 (1.16–2.92)** 1.55 (0.95–2.54) 1.40 (0.83–2.37) 1.33 (0.78–2.28)
Age 1.05 (1.00–1.11) 1.05 (0.99–1.11) 1.06 (1.00–1.12)
Sex (male) 0.51*** (0.35–0.74) 0.42** (0.26–0.68) 0.44** (0.27–0.72)
Education level (primary) 1.39 (0.95–2.04) 1.43 (0.96–2.12) 1.53* (1.02–2.29)
BMI 0.99 (0.95–1.03) 0.98 (0.94–1.03)
ADL (lowest gender-specific quintile) 1.04 (0.61–1.78) 1.27 (0.73–2.23)
Grip strength (lowest gender-specific quartile) 0.68 (0.41–1.11) 0.63 (0.38–1.04)
PPT (lowest gender-specific quartile) 1.07 (0.62–1.87) 1.03 (0.58–1.83)
GDS-15 (⩾5) 1.80* (1.08–3.00) 1.71* (1.00–2.90)
Non-respiratory morbidity 0.96 (0.90–1.04)
COPD/asthma 0.50* (0.29–0.88)
Multimorbidity was based on simple disease count of coronary heart disease, myocardial infarction, diabetes, atrial fibrillation, peripheral arterial disease,
stroke, hypertension, Parkinson’s disease, arthritis or osteoarthritis, fractures and cancer.
Abbreviations: ADL, activity of daily living; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GDS-15, 15-item Geriatric Depression Scale;
MMSE, mini-mental state examination; PPT, physical performance test.
*P o0.05, **Po0.01, ***Po0.001.
Table 1. Baseline characteristics of the BELFRAIL study population in total and across the categories of spirometry quality
Characteristics Spirometry quality P Total population
ATS 1 (n= 226) ATS 2–4 (n= 296)
Age(years), mean± s.d. 84.3± 3.2 85.1± 4.0 0.01a 84.71± 3.7
Sex (men), n (%) 105 (46.5) 87 (29.4) o0.001b 192 (36.8)
BMI (kg/m2), mean± s.d. 27.3± 4.7 27.4± 5.0 0.82a 27.3 (4.9)
Education level, n (%)
Primary 72 (32.1) 119 (40.6) 0.13b 191 (36.6)
Secondary 121 (54) 142 (48.5) 263 (50.4)
Higher 31 (13.8) 32 (10.9) 63 (12.1)
Current/previous smoker, n (%) 87 (39.9) 77 (26.9) 0.002b 164 (31.4)
COPD/asthma, n (%) 44 (20.2) 27 (9.4) 0.001b 71 (13.6)
Non-respiratory co-morbidity, median (IQR) 4 (3–6.25) 5 (3–7) 0.349c 5 (3–7)
mMRC, n (%)
Grade 0 101 (44.7) 128 (43.4) 0.40b 229 (44)
Grade 1 56 (24.8) 87 (29.5) 143 (27.4)
Grade 2 30 (13.3) 25 (8.5) 55 (10.6)
Grade 3 32 (14.2) 46 (15.6) 78 (15)
Grade 4 7 (3.1) 9 (3.1) 16 (3)
MMSE score, median (IQR) 28 (26–29) 27 (25–29) 0.002c 28 (26–29)
MMSE categories, n (%)
Normal (⩾25) 194 (85.8) 227 (76.7) 0.010b 421 (80.7)
Cognitive impairment (⩽24) 32 (14.2) 69 (23.3) 101 (19.3)
Mild (24–21) 23 (10.2) 40 (13.5) 0.279b 63 (12.1)
Moderate (20–10) 8 (3.5) 27 (9.1) 0.013b 35 (6.6)
Severe (⩽9) 1 (0.5) 2 (0.7) 1.0b 3 (0.6)
GDS-15 score, median (IQR) 2 (1–3) 2.5 (1–5) 0.004c 2 (1–4)
GDS-15 categories
Normal (o5) 194 (85.8) 220 (74.3) 0.001b 414 (79.3)
At risk for depression (⩾5) 32 (14.2) 76 (25.7) 108 (20.7)
ADL score, median (IQR) 26 (22–29) 24 (20–27) 0.004c 25 (21–27)
Grip strength (kg), median (IQR) 21.8 (17.3–28.2) 19.9 (14.8–26.1) 0.004c 20. (16.1–27.1)
PPT score (0–14), median (IQR) 9 (6–11) 9 (5–11) 0.527c 9 (5–11)
Non-respiratory co-morbidity was based on simple disease count of general practitioner-reported anaemia, Parkinson’s disease, arthritis, osteoarthritis,
osteoporosis, cancer, depression, hypertension, diabetes, angina pectoris, myocardial infarction, cardiomyopathy, transient ischaemic attacks, cerebrovascular
accidents, peripheral arterial disease, decompensated heart failure, valvular disease, thyroid dysfunction, renal failure, hyperlipidaemia, atrial fibrillation.
Abbreviations: ADL, activity of daily living; ATS, American Thoracic Society; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GDS-15,
15-item Geriatric Depression Scale; IQR, interquartile range; mMRC, modified Medical Research Council dyspnoea scale; MMSE, mini-mental state examination;
PPT, physical performance test.
aP based on t-test for independent samples.
bP based on Pearson χ2 test.
cP based on Mann–Whitney U-test.
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marker for adverse health outcomes in older adults can be
assessed in spirograms in which plateau of 46 s has not been
reached (spirometry quality levels ATS 1–3 are usable for this
purpose and were achieved by 96% of participants in the
BELFRAIL and 80% of participants in the CRYSTAL study).4–8
Almost all the previous studies in older adults have reported a
significant association between cognitive impairment (based
on MMSE scores) and poor-quality spirometry, yet the definitions
of cognitive impairment and quality spirometry differ between
studies and most of their populations were inpatient or
ambulatory patients with geriatric or respiratory
problems.15–18,25,26,35,36 Only one previous study with a small
number of independent participants attending a community
centre has reported no association between poor-quality
spirometry and MMSE scores, although it found an association
with one of two other cognitive function tests that measure
executive function to perform simple-directed tasks.24 In our
study, cognitive impairment based on MMSE ⩽ 24 was not
associated with poor-quality spirometry after adjustment for
age, sex, BMI, level of education (BELFRAIL cohort only), physical
functioning, affective status and co-morbidity. In the light of our
findings and the fact that previous studies have focused on
respiratory or geriatrics in/outpatients, it remains an issue for
further research whether cognitive impairment (based on MMSE
scores) is an independent predictor for poor-quality spirometry in
community-dwelling older adults.
In the BELFRAIL cohort, asthma/COPD diagnosis halved the
odds for poor-quality spirometry, probably because of previous
Table 3. Baseline characteristics of the CRYSTAL study population in total and across the categories of spirometry quality
Characteristics Spirometry quality P Total population
ATS 1 (n= 349) ATS 2–4 (n=256)
Age (years), mean± s.d. 74.8± 5.9 75.4± 5.9 0.11a 75.11± 6.0
Age group, n (%)
65–79 years old 268 (76.8) 186 (72.7) 0.25b 454 (75)
⩾ 80 years old 81 (23.2) 70 (27.3) 151 (25)
Sex (male), n (%) 104 (29.8) 66 (25.8) 0.31b 170 (28.1)
BMI (kg/m2), mean± s.d. 28.7± 5.1 28.4± 4.8 0.32a 28.6± 5.0
Current/previous smoker, n (%) 61 (17.5) 46 (18) 0.91b 107 (17.7)
COPD/asthma, n (%) 83 (23.8) 62 (24.2) 0.92b 145 (24)
Non-respiratory co-morbidity, median (IQR) 2 (1–3) 2 (1–3) 0.74c 2 (1–3)
mMRC, n (%)
Grade 0 102 (29.6) 72 (28.6) 0.21b 174 (29.1)
Grade 1 170 (49.3) 113 (44.8) 283 (47.4)
Grade 2 42 (12.2) 29 (11.5) 71 (11.9)
Grade 3 22 (6.4) 24 (9.5) 46 (7.7)
Grade 4 9 (2.6) 14 (5.6) 23 (3.9)
MMSE score, median (IQR) 26 (24–28) 26 (23–28) 0.02c 26 (23–28)
MMSE score, n (%)
Normal (⩾25) 240 (68.8) 156 (60.9) 0.047b 396 (65.5)
Cognitive impairment (⩽24) 109 (31.2) 100 (39.1) 209 (34.5)
Mild (21–24) 66 (18.9) 58 (22.7) 0.26b 124
Moderate (20–10) 40 (11.5) 38 (14.8) 0.22b 78
Severe (9) 3 (0.9) 4 (1.6) 0.46b 7
GDS-15 score, median (IQR) 4 (2–6.7) 4 (2–7) 0.05c 4 (2–7)
GDS-15 score, n (%)
Normal (o5) 200 (57.3) 127 (49.6) 0.07b 327 (54)
At risk for depression (⩾5) 149 (42.7) 129 (50.4) 278 (46)
Barthel Index score, median (IQR) 100 (95–100) 93.7 (95–100) 0.45c 100 (95–100)
Barthel Index, n (%)
Independent (⩾95) 263 (75.4) 199 (77.7) 0.56b 462 (76.4)
Dependent (o95) 86 (24.6) 57 (22.3) 143 (23.6)
Grip strength (kg), median (IQR) 15.7 (11.1–20.9) 16.3 (11.7–23.0) 0.07c 16.3 (11.7–21.7)
PPT score (0–14), median (IQR) 9 (6–11) 9 (5–12) 0.89c 9 (6–11)
Non-respiratory co-morbidity was based on simple disease count of coronary heart disease, myocardial infarction, diabetes, atrial fibrillation, peripheral arterial
disease, stroke, hypertension, Parkinson’s disease, arthritis or osteoarthritis, fractures and cancer.
Abbreviations: ATS, American Thoracic Society; BMI, body mass index; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; mMRC, modified
Medical Research Council dyspnoea scale; MMSE, Mini mental state examination; GDS-15, 15-item Geriatric Depression Scale; PPT, physical performance test.
aP based on t-test for independent samples.
bP based on Pearson χ2 test.
cP based on Mann–Whitney U-test.
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‘learning’ experience with spirometry in those with asthma/COPD.
Although female sex has been previously found to be a predictor
of good-quality spirometry,14 in the BELFRAIL cohort we found
that male sex almost halved the odds for poor-quality spirometry.
This may be explained by the significantly higher prevalence of
COPD/asthma in men in this cohort.
Strengths and limitations of this study
One of the limitations of this study is the exclusion criteria
for participants of the BELFRAIL study (dementia or severe
cognitive impairment or being in palliative or emergency care),
but similar exclusion criteria have been applied in other
previous studies on this topic.15,18,24 In the CRYSTAL study, it has
not been possible to identify the clinical research assistants for
each spirometry to analyse the effect of the variability of four
different operators on the spirometry quality. Besides the
participants’ characteristics, the operator’s interpersonal skills to
instruct, engage and support/coach the patient through the
spirometry manoeuver are crucial in achieving quality
spirometry.14,37 There were also incomplete data on the education
level in the CRYSTAL study to correct for its influence in
multivariable analysis. The tests used to assess mental and
physical functioning in both the studies are designed for
screening purposes and may have under/overestimated the level
of physical or mental impairment.
One of the strengths of this study is that it reports from two
large heterogeneous cohorts of community-dwelling older adults
in two countries such as Belgium and Russia with different socio-
demographic and epidemiological contexts.21,22 Both study
protocols included a standardised comprehensive geriatric
assessment of the participants. Rigorous quality control of
spirometry performance and interpretation based on the ATS/
ERS quality criteria were followed. Statistical multivariable analysis
included most of the key factors previously reported as
determinants of the spirometry quality in older adults.
Implications for future research, policy and practice
Further studies are needed on cognitive impairment as a predictor
of poor-quality spirometry in community-dwelling older adults.
Spirometry should be used more frequently in older adults in
primary care without prejudice on age and mental and/or physical
functioning, as it is a valuable tool not only for the diagnosis and
management of respiratory diseases, but also for assessing overall
health and risk for adverse outcomes in this worldwide growing
age group.
Conclusions
In community-dwelling older adults, including those over 80 years
old, impaired cognition measured by the MMSE may not be
an independent predictor of poor-quality spirometry. Further
research is needed in this area, and spirometry should be used
more often in older adults in primary care.
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Table 4. Multivariable logistic regression analysis of the association between MMSE score and poor spirometry quality in the CRYSTAL study
Variables Unadjusted Model 1 Model 2 Model 3
MMSE (⩽24) 1.41 (1.01–1.98)* 1.33 (0.92–1.90) 1.28 (0.87–1.90) 1.30 (0.88–1.91)
Age 1.01 (0.98–1.04) 1.01 (0.98–1.04) 1.01 (0.98–1.04)
Sex (male) 0.82 (0.56–1.20) 0.88 (0.54–1.44) 0.88 (0.54–1.44)
BMI 0.98 (0.95–1.02) 0.98 (0.95–1.02) 0.98 (0.95–1.02)
Barthel Index (o95) 0.63 (0.41–0.99)* 0.65 (0.41–1.02)
Grip strength (lowest gender-specific quartile) 1.11 (0.67–1.82) 1.11 (0.67–1.83)
PPT (lowest gender-specific quartile) 1.15 (0.77–1.71) 1.15 (0.77–1.72)
GDS-15(⩾5) 1.25 (0.86–1.81) 1.27 (0.87–1.85)
Multimorbidity (⩾2 diseases) 0.82 (0.57–1.18)
COPD/asthma 1.01 (0.68–1.49)
Multimorbidity was based on simple disease count of coronary heart disease, myocardial infarction, diabetes, atrial fibrillation, peripheral arterial disease,
stroke, hypertension, Parkinson’s disease, arthritis or osteoarthritis, fractures and cancer.
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; GDS-15, 15-item Geriatric Depression Scale; MMSE, mini-mental state
examination; PPT, physical performance test.
*Po0.05.
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